Is Alphabet Stock No Longer a Good Bet?
Alphabet tripled its price per share over the past 5…
Sell
32
NVAX Quote, Financials, Valuation and Earnings
Last price:
$7.91
Seasonality move
:
19.83%
Day range:
$7.81 - $8.36
52-week range:
$3.81 - $23.86
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.82x
P/B ratio:
--
Volume:
4.2M
Avg. volume:
4.3M
1-year change:
54.67%
Market cap:
$1.3B
Revenue:
$682.2M
EPS (TTM):
-$1.33
Novavax SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
NVAX
Novavax
|
05/10/2024 | 10-Q | 10-Q filing on 05/10/2024 | View Form |
|
NVAX
Novavax
|
02/28/2024 | 10-K | 10-K filing on 02/28/2024 | View Form |
|
NVAX
Novavax
|
11/09/2023 | 10-Q | 10-Q filing on 11/09/2023 | View Form |
|
NVAX
Novavax
|
08/08/2023 | 10-Q | 10-Q filing on 08/08/2023 | View Form |
|
NVAX
Novavax
|
05/09/2023 | 10-Q | 10-Q filing on 05/09/2023 | View Form |
|
NVAX
Novavax
|
02/28/2023 | 10-K | 10-K filing on 02/28/2023 | View Form |
|
NVAX
Novavax
|
11/09/2022 | 10-Q | 10-Q filing on 11/09/2022 | View Form |
|
NVAX
Novavax
|
08/09/2022 | 10-Q | 10-Q filing on 08/09/2022 | View Form |
|
NVAX
Novavax
|
05/10/2022 | 10-Q | 10-Q filing on 05/10/2022 | View Form |
|
NVAX
Novavax
|
03/01/2022 | 10-K | 10-K filing on 03/01/2022 | View Form |
|
NVAX
Novavax
|
11/05/2021 | 10-Q | 10-Q filing on 11/05/2021 | View Form |
|
NVAX
Novavax
|
08/05/2021 | 10-Q | 10-Q filing on 08/05/2021 | View Form |
|
NVAX
Novavax
|
05/10/2021 | 10-Q | 10-Q filing on 05/10/2021 | View Form |
|
NVAX
Novavax
|
04/30/2021 | 10-K | 10-K filing on 04/30/2021 | View Form |
|
NVAX
Novavax
|
03/01/2021 | 10-K | 10-K filing on 03/01/2021 | View Form |
|
NVAX
Novavax
|
11/10/2020 | 10-Q | 10-Q filing on 11/10/2020 | View Form |
|
NVAX
Novavax
|
08/10/2020 | 10-Q | 10-Q filing on 08/10/2020 | View Form |
|
NVAX
Novavax
|
05/11/2020 | 10-Q | 10-Q filing on 05/11/2020 | View Form |
|
NVAX
Novavax
|
04/29/2020 | 10-K | 10-K filing on 04/29/2020 | View Form |
|
NVAX
Novavax
|
03/11/2020 | 10-K | 10-K filing on 03/11/2020 | View Form |
|
NVAX
Novavax
|
11/07/2019 | 10-Q | 10-Q filing on 11/07/2019 | View Form |
|
NVAX
Novavax
|
08/07/2019 | 10-Q | 10-Q filing on 08/07/2019 | View Form |
|
NVAX
Novavax
|
05/02/2019 | 10-Q | 10-Q filing on 05/02/2019 | View Form |
|
NVAX
Novavax
|
04/30/2019 | 10-K | 10-K filing on 04/30/2019 | View Form |
|
NVAX
Novavax
|
03/18/2019 | 10-K | 10-K filing on 03/18/2019 | View Form |
|
NVAX
Novavax
|
11/07/2018 | 10-Q | 10-Q filing on 11/07/2018 | View Form |
|
NVAX
Novavax
|
08/08/2018 | 10-Q | 10-Q filing on 08/08/2018 | View Form |
|
NVAX
Novavax
|
05/09/2018 | 10-Q | 10-Q filing on 05/09/2018 | View Form |
|
NVAX
Novavax
|
03/14/2018 | 10-K | 10-K filing on 03/14/2018 | View Form |
|
NVAX
Novavax
|
11/07/2017 | 10-Q | 10-Q filing on 11/07/2017 | View Form |
|
NVAX
Novavax
|
08/08/2017 | 10-Q | 10-Q filing on 08/08/2017 | View Form |
|
NVAX
Novavax
|
05/08/2017 | 10-Q | 10-Q filing on 05/08/2017 | View Form |
|
NVAX
Novavax
|
02/27/2017 | 10-K | 10-K filing on 02/27/2017 | View Form |
|
NVAX
Novavax
|
11/09/2016 | 10-Q | 10-Q filing on 11/09/2016 | View Form |
|
NVAX
Novavax
|
08/09/2016 | 10-Q | 10-Q filing on 08/09/2016 | View Form |
|
NVAX
Novavax
|
05/05/2016 | 10-Q | 10-Q filing on 05/05/2016 | View Form |
|
NVAX
Novavax
|
02/29/2016 | 10-K | 10-K filing on 02/29/2016 | View Form |
|
NVAX
Novavax
|
11/09/2015 | 10-Q | 10-Q filing on 11/09/2015 | View Form |
|
NVAX
Novavax
|
08/10/2015 | 10-Q | 10-Q filing on 08/10/2015 | View Form |
|
NVAX
Novavax
|
05/07/2015 | 10-Q | 10-Q filing on 05/07/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
52
RGC alert for Mar 19
Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.
Sell
49
SRPT alert for Mar 19
Sarepta Therapeutics [SRPT] is up 8.72% over the past day.
Sell
46
CVNA alert for Mar 19
Carvana [CVNA] is up 5.74% over the past day.
